Savory Ingredients

Savory Ingredients

Pharmaceutical glass packaging refers to a type of packaging made from a variety of glass components and designed to ensure the secure carriage of various medical products. By nature, glass is so resistant to temperature changes, using it for pharmaceutical packaging presents many advantages. Glass is extensively used to package a variety of pharmaceutical drugs and medicines. Ultra-resistant borosilicate glass, soda-lime glass with a surface treatment, normal soda-lime glass, and soda-lime glass for general use are some of the widely used pharmaceutical glass packaging materials. It prevents ambient gases like carbon dioxide and oxygen from accessing the main container, therefore eliminating the possibility of medication contamination. It also helps extend the shelf life of pharmaceutical products and prevents the volatile chemicals/ingredients from escaping, thereby increasing medicinal stability. Pharmaceutical glass packaging has exceptional strength, durability, clarity, recyclability, and chemical resistance, and has rapidly gained prominence in recent years.

The pharmaceutical glass packaging market is expected to grow at a steady rate of around 8%. Expansion of the pharmaceutical industry is to act as a major driving factor for the growth of the market. The rise in demand for generic drugs and medicines in developing economies as well as emerging markets owing to higher consumer healthcare consciousness and low-cost initiatives carried out by governments is anticipated to drive the market growth during the period of forecast. Furthermore, the latest technological advancements and innovations and their implementation in pharmaceutical glass packaging manufacturing processes will boost the growth of the market during the forecast period. For instance, in November 2021, Corning Incorporated launched coated, specially engineered, Type I borosilicate vials known as Corning Velocity Vials. These vials exhibit effective hardness compared to conventional borosilicate vials, reducing the chances of cracking and breaking.

Based on product, the market is segmented into bottles, vials, ampoules, cartridges and syringes and others. Among them, the bottle category is expected to offer rewarding opportunities for the growth and expansion of the market during the forecast period owing to its attributes of chemical inertness, rigidity, and superior protective qualities. Additionally, the bottles segment has gained popularity in the packaging of both solid as well as liquid pharmaceutical preparations such as tablets, capsules, syrups, and ophthalmic offerings. The surge in demand for the bottles category in the pharmaceutical industry is projected to propel market growth. Vials segment will also hold a significant CAGR during the period of forecast. Owing to the presence of its better analytical performance and sustainability. Vials prevents external/atmospheric gases from damaging the product contained in the glass packaging. Additionally, they are also widely used in the collection of biological samples.

Based on drug type, the market is divided into generic, branded and biologic. Among them, the generic segment held the maximum market share and is expected to maintain its position during the period forecast. Generic drugs are low in cost as compared to branded drugs with the same composition. Initiatives taken by the government for promoting the use of generic drugs are fueling the growth of the market. Furthermore, patent expiration of branded drugs also acts as a major factor for the growth of the generic drugs category. Developing nations have a high demand for branded drugs, which ultimately propels the growth for generic drugs.

Based on application, the market is segmented into oral, injectable, nasal and others. Among them, the injectable category is anticipated to witness the highest CAGR during the forecast period. Owing to the extensive usage of medicines and drugs in the form of injections to properly and effectively give dosage to patients from vials, cartridges, ampoules,etc.

For a better understanding of the market adoption of the pharmaceutical glass packaging industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America holds the major market share in the pharmaceutical glass packaging market and is anticipated to grow at a substantial CAGR during the forecast period. The major reason for the growth of the market is the expansion of the pharmaceutical industry in the region. Increased spending on healthcare units coupled with technological advancements is driving the market growth. Additionally, the growing prevalence of infectious and chronic diseases is propelling the growth in the region. Asia-Pacific is expected to be the fastest-growing segment during the forecast period owing to growing population rates in this region. Europe also holds a significant CAGR and accounted for more than 20% share of the total market. It recognizes the need for pharmaceutical packaging. Government initiatives that supply priority medicines are anticipated to be beneficial for the pharmaceutical industry. Another major reason for the growth in the region is the new product introduction, mergers and acquisitions made by key market players. For instance, In March 2021, Stoelzle Glass Group acquired the Monaca, Pennsylvania, glass factory of Anchor Hocking Glass Company. The Oneida Group is the parent company of Anchor Hocking Glass Company. With the new acquisition, it will open its seventh glass plant in the United States and its first outside Europe.

Some of the major players operating in the market include Corning Incorporated, Nipro Europe Group Companies, SGD Pharma, Stoelzle Glass Group, Gerresheimer AG, Schott AG, Bormioli Pharma S.p.A., PGP Glass, West Pharmaceutical Services, Inc, Ardagh Group S.A. "
"The savory ingredients market is expected to register a CAGR of approx. 5.2% over the period of 2023-2030. Savory additives are flavour enhancers that change the taste of food items during processing to increase product quality and shelf life. These food additives contribute to the improvement of the fragrance, flavor, and taste of food products. These substances impart a natural aromatic taste and are commonly used in the manufacture of quick meals, meat products, nutritious food, and spices. The growing demand for savory Ingredients can be attributed to rising demand for packaged instant food products and rapid urbanization has become increasingly attractive to investors owing to the technology-driven innovations contributing to market penetration. For instance, in December 2019, Angel Yeast Co. ltd launched a new natural flavor-enhancing solution for plant based food and beverages in Europe. This product launch will help the company to strengthen its portfolio and increase its customer base in Europe. Furthermore, influence of western food habits is anticipated to grow on account of the increased urban taste among new generation and hence, increasing the demand for savory ingredients market. However, the growing awareness regarding the ill-effects of synthetic savory ingredients such as MSG, is one of the key factors restricting the growth of this market in developed regions, where the consumers are more inclined toward natural ingredients such as yeast extracts.

Based on the type, the savory ingredients market is segmented into starches, proteins, yeast, monosodium glutamate (MSG) and others. The monosodium glutamate (MSG) segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Its utilization helps increase the product shelf-life and minimize the salt content in food preparation.

Based on the source, the market is fragmented into natural and synthetic. The natural segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Moreover, the rising mindfulness about the medical benefits of natural food items and the progress in organic cultivating procedures is anticipated to drive the demand for natural nourishment and drinks.

Based on the application, the market is fragmented into food and feed. The food segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. This is attributable to the high consumption of savory ingredients such as MSG as well as yeast extracts, in numerous food applications, like packaged snacks and frozen meals.

For a better understanding of the market adoption of the savory Ingredients, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. Asia-Pacific constitutes a major market for the savory ingredients industry owing to due to the large-scale consumption of savory snacks, soups, and curated meat products. The Asia Pacific region is an emerging economy in the market which is anticipated to create opportunities for numerous other food manufacturers in the region. For instance, the surging consumption of noodles in evolving economies like China and India due to increasing working professionals, busy lifestyles, and the growing young population. Countries like China consume large quantities of MSG, specifically in the HoReCa sector. The majority of noodles brands integrate MSG, starch, and yeast extract thus the mounting demand for instant noodles and similar convenience food products is expected to augment the market growth rate of the savory ingredients market.

Some of the major players operating in market are Ajinomoto ADR Representing One Ord Shs; AngelYeast Co., Ltd.; Archer-Daniels-Midland Co; Associated British Foods ADR; Cargill Incorporated; Givaudan ADR; Kerry Group PLC – ADR; Koninklijke DSM N.V.; Sensient Technologies Corp; Symrise among others. Several M&A’s along with partnerships have been undertaken by these players. "